The purpose of this rule is to
establish a standardized format for the labeling of all OTC drug
products so that the labeling will be easier to read and have
consistent text in like situations. Variability in the design,
format, and placement of required OTC drug product labeling
information may make it difficult for consumers to both find and
read safety information. For consumers to benefit from safety
information, it must not only be readily accessible, but it must
also be readable, readily understood, noted, and acted upon. If
information is not processed or is ignored due to factors
affecting....
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.